Literature DB >> 30822298

Malignant Glaucoma After Laser Peripheral Iridotomy.

Jason A Greenfield1, William E Smiddy, David S Greenfield.   

Abstract

PURPOSE: We describe a patient with primary angle-closure glaucoma who developed malignant glaucoma following laser peripheral iridotomy.
METHODS: A 58-year-old male presented with peripheral and central anterior chamber shallowing following an uncomplicated Nd: YAG laser peripheral iridotomy. Intraocular pressure (IOP) and B-scan echography were normal, and there was -1.5 Ddiopter asymmetric myopia. Despite treatment with aqueous suppression and cycloplegia for 7 months, the patient developed progressive myopic shift and anterior chamber shallowing.
RESULTS: The patient underwent 23-G pars plana vitrectomy and lensectomy using a standard 3-port technique, and sulcus posterior chamber intraocular lens implantation in the left eye. Twelve months postoperatively, the anterior chamber has remained deep, best-corrected visual acuity is 20/15, and the IOP is 11 mm Hg.
CONCLUSIONS: Malignant glaucoma is a rare complication of laser iridotomy and should be considered in eyes with progressive anterior chamber shallowing and myopia despite normal IOP.

Entities:  

Mesh:

Year:  2019        PMID: 30822298     DOI: 10.1097/IJG.0000000000001145

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  2 in total

1.  Intraoperative malignant glaucoma during femtosecond laser-assisted cataract surgery: A case report.

Authors:  Rong Xu; Danmin Cao; Ya Jiao; Qingyan Zeng
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

2.  Management of a Bilateral Post-Uveitic Complex Glaucoma with Pupillary Block, Rupture of the Anterior Lens Capsule, and Malignant Glaucoma following Laser Peripheral Iridotomies: Case Report and Literature Review.

Authors:  Khaled El Matri; Dhouha Gouider; Rim Limaiem; Ahmed Chebil; Meher Henchiri; Yousra Falfoul; Leila El Matri
Journal:  J Curr Ophthalmol       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.